Selective vulnerability in amyotrophic lateral sclerosis: no evidence for a contribution of annexins, a family of calcium binding proteins

References

• Mitsumoto H, Chad DA, Pioro EP, editors. Amyotrophic Lateral Sclerosis. Philadelphia: FA Davies Company, 1998.
   Google Scholar
• Ince P, Stout N, Shaw P et al. Parvalbumin and calbindin D-28K in the human motor system and in motor neuron disease. Neuropathol Appl Neurobiol 1993; 19: 291–299.
   PubMed Web of Science ®Google Scholar
• Alexianu ME, Ho B-K, Mohamed AH, La Bella V, Smith RG, Appel SH. The role of calcium-binding proteins in selective motor neuron vulnerability in amyotrophic lateral sclerosis. Ann Neurol 1994; 36: 846–858.
   PubMed Web of Science ®Google Scholar
• Raynal P, Pollard HB. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochem Biophys Acta 1994; 1197: 63–93.
   PubMed Web of Science ®Google Scholar
• Baimbridge KG, Celio MR, Rogers JH. Calcium binding proteins in the nervous system. TINS 1992; 15: 303–308.
   PubMed Web of Science ®Google Scholar
• Black MD, Carey F, Crossman AR, Relton JK, Rothwell NJ. Lipocortin-1 inhibits NMDA receptor-mediated neuronal damage in the striatum of the rat. Brain Res 1992; 585: 135–140.
   PubMed Web of Science ®Google Scholar
• Naciff JM, Kaetzel MA, Behbehani MM, Dedman JR. Differential expression of annexins I-VI in the rat dorsal root ganglia and spinal cord. J Comp Neurol 1996; 368: 356–370.
   PubMed Web of Science ®Google Scholar
• Dreier R, Schmid KW, Gerke V, Riehemann K. Differential expression of annexins I, II and IV in human tissues: an immunohistochemical study. Histochem Cell Biol 1998; 110: 137–148.
   PubMed Web of Science ®Google Scholar
• Eberhard DA, Brown MD, VandenBerg SR. Alterations of annexin expression in pathological neuronal and glial reactions. Immunohistochemical localization of annexins I, II (p36 and p11 subunits), IV, and VI in the human hippocampus. Am J Pathol 1994; 145: 640–649.
   Google Scholar
• Selbert S, Fischer P, Menke A, Jockusch H, Pongratz D, Noegel AA. Annexin VII relocalization as a result of dystrophin deficiency. Exp Cell Res 1996; 222: 199–208.
   PubMed Web of Science ®Google Scholar
• Wulfkuhle JD, Sgroi DC, Krutzsch H et al. Proteomics of human breast ductal carcinoma in situ. Cancer Res 2002; 62: 6740–6749.
   PubMed Web of Science ®Google Scholar
• Hansen MDH, Ehrlich JS, Nelson WJ. Molecular mechanism for orienting membrane and actin dynamics to nascent cell-cell contacts in epithelial cells. J Biol Chem 2002; 277: 45371–45376.
   PubMed Web of Science ®Google Scholar
• Babiychuk EB, Palstra RJ, Schaller J, Kampfer U, Draeger A. Annexin VI participates in the formation of a reversible, membrane-cytoskeleton complex in smooth muscle cells. J Biol Chem 1999; 274: 35191–35195.
   PubMed Web of Science ®Google Scholar
• Matteo RG, Moravec CS. Immunolocalization of annexins IV, V and VI in the failing and non-failing human heart. Cardiovasc Res 2000; 45: 961–970.
   PubMed Web of Science ®Google Scholar
• Bergmann M. Motor neuron disease/amyotrophic lateral sclero- sis: lessons from ubiquitin. Path Res Pract 1993; 189: 902–912.
   PubMed Web of Science ®Google Scholar
• Bergmann M, Vo¨ lpel M, Kuchelmeister K. Onuf ’s nucleus is frequently involved in motor neuron disease/amyotrophic lateral sclerosis. J Neurol Sci 1995; 129: 141–146.
   Google Scholar
• Celio MR, Heizmann CW. Calcium-binding protein parvalbumin as a neuronal marker. Nature 1981; 293: 300–302.
   PubMed Web of Science ®Google Scholar
• Meldrum B, Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci 1990; 11: 379–387.
   PubMed Web of Science ®Google Scholar
• Mannen T, Iwata M, Toyokura Y, Nagashima K. Preservation of a certain motor neuron group of the sacral cord in amyotrophic lateral sclerosis: its clinical significance. J Neurol Neurosurg Psych 1977; 40: 464–469.
   PubMed Web of Science ®Google Scholar
• Iwata M, Inoue K, Mannen T. Functional localization in the Onufrowicz nucleus in man. Clin Neuropathol 1993; 12: 112–116.
   PubMed Web of Science ®Google Scholar
• Konno H, Yamamoto T, Iwasaki Y, Iizuka H. Shy-Drager syndrome and amyotrophic lateral sclerosis. Cytoarchitectonic and morphometric studies of sacral autonomic neurons. J Neurol Sci 1986; 73: 193–204.
   Google Scholar
• Onufrowicz B. The arrangement and function of the cell groups of the sacral region of the spinal cord in man. Arch Neurol Psychopathol 1900; 3: 387–412.
   Google Scholar
• Carpenter MB, Sutin J, editors. Human Neuroanatomy. Baltimore: Williams and Wilkins, 1983.
   Google Scholar
• Okamoto K, Hirai S, Amari M et al. Oculomotor nuclear pathology in amyotrophic lateral sclerosis. Acta Neuropathol 1993; 85: 458–462.
   Google Scholar
• Holstege G, Tan J. Supraspinal control on motor neuron innervating the striated muscles of pelvic floor including urethral and anal sphincters in the cat. Brain 1987; 110: 1323–1344.
   PubMed Web of Science ®Google Scholar
• Migheli A, Piva R, Atzori C, Troost D, Schiffer D. c-Jun, JNK/ SAPK kinases and transcription factor NF-kappa B are selectively activated in astrocytes, but not motor neurons, in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 1997; 56: 1314–1322.
   PubMed Web of Science ®Google Scholar
• Iglesias JM, Morgan RO, Jenkins NA, Copeland NG, Gilbert DJ, Fernandez MP. Comparative genetics and evolution of annexin A13 as the founder of vertebrate annexins. Mol Biol Evol 2002; 19: 608–618.
   PubMed Web of Science ®Google Scholar
• Morgan RO, Jenkins NA, Gilbert DJ et al. Novel human and mouse annexin A10 are linked to the genome duplications during early chordate evolution. Genomics 1999; 60: 40–49.
   Google Scholar
• Dubois T, Oudinet JP, Mira JP, Russo Marie F. Annexins and protein kinases C. Biochem Biophys Acta 1996; 1313: 290–294.
   PubMed Web of Science ®Google Scholar
• Rhee HJ, Kim GY, Huh JW, Kim SW, Na DS. Annexin I is a stress protein induced by heat, oxidative stress and a sulfhydryl-reactive agent. Eur J Biochem 2000; 267: 3220–3225.
   PubMedGoogle Scholar
• Do¨ ring V, Veretout F, Albrecht R et al. The in vivo role of annexin VII (synexin): characterization of an annexin VII-deficient Dictyostelium mutant indicates an involvement in Ca2z regulated processes. J Cell Sci 1995; 108: 2065–2076.
   Google Scholar
• Herr C, Smyth N, Ullrich S et al. Loss of annexin A7 leads to alterations in frequency-induced shortening of isolated murine cardiomyocytes. Mol Cell Biol 2001; 21: 4119–4128.
   Google Scholar
• Johnson MD, Kamso-Pratt J, Whetsell WO, Pepinsky RB. Lipocortin-1 immunoreactivity in the normal human central nervous system and lesions with astrocytosis. Am J Clin Pathol 1989; 92: 424–429.
   PubMed Web of Science ®Google Scholar
• Probst-Cousin S, Kowolik D, Kuchelmeister K, Kayser C, Neundo¨ rfer B, Heuss D. Expression of annexin-1 in multiple sclerosis plaques. Neuropathol Appl Neurobiol 2002; 28: 292–300.
   Google Scholar
• Flower RJ. Lipocortin and the mechanisms of action of the glucocorticoids. Br J Pharmacol 1988; 94: 987–1015.
   PubMed Web of Science ®Google Scholar
• Goulding NJ, Guyre PM. Glucocorticoids, lipocortins and the immune response. Curr Opin Immunol 1993; 5: 108–113.
   PubMed Web of Science ®Google Scholar
• Johnson MD, Kamso-Pratt J, Pepinsky RB, Whetsell WO. Lipocortin-1 immunoreactivity in central and peripheral nervous system glial tumours. Hum Pathol 1989; 20: 772–776.
   PubMed Web of Science ®Google Scholar
• Flower RJ, Rothwell NJ. Lipocortin-1: cellular mechanisms and clinical relevance. Trends Pharmacol Sci 1994; 15: 71–76.
   PubMed Web of Science ®Google Scholar
• Relton JK, Strijbos PJ, O’Shaughnessy CT et al. Lipocortin-1 is an endogenous inhibitor of ischaemic damage in the rat brain. J Exp Med 1991; 174: 305–310.
   Google Scholar
• Nilius B, Gerke V, Prenen J et al. Annexin II modulates volume- activated chloride currents in vascular endothelial cells. J Biol Chem 1996; 271: 30613–30616.
   Google Scholar
• Redlitz A, Plow EF. Receptors for plasminogen and t-PA: an update. Baillieres Clin Haematol 1995; 8: 313–327.
   PubMedGoogle Scholar
• Greenberg ME, Brackenbury R, Edelmann GM. Changes in the distribution of the 34-kdalton tyrosine kinase substrate during differentiation and maturation of chicken tissues. J Cell Biol 1984; 98: 9473–9486.
   Web of Science ®Google Scholar
• Chan HC, Kaetzel MA, Gotter AL, Dedman JR, Nelson DJ. Annexin IV inhibits calmodulin-dependent protein kinase II- activated chloride conductance. A novel mechanism for ion channel regulation. J Biol Chem 1994; 269: 32464–32468.
   Google Scholar
• Kaetzel MA, Chan HC, Dubinsky WP, Dedman JR, Nelson DJ. A role for annexin IV in epithelial cell function. Inhibition of calcium-activated chloride conductance. J Biol Chem 1994; 269: 5297–5302.
   Google Scholar
• Weinman JS, Feinberg JM, Rainteau DP, Gaspera BD, Weinman SJ. Annexins in rat enterocyte and hepatocyte: an immunogold electron-microscope study. Cell Tissue Res 1994; 278: 389–397.
   PubMed Web of Science ®Google Scholar
• Hamre KM, Chepenik KP, Goldowitz D. The annexins: specific markers of midline structures and sensory neurons in the developing murine central nervous system. J Comp Neurol 1995; 352: 421–435.
   PubMed Web of Science ®Google Scholar
• van-Engeland M, Nieland LJ, Ramaekers FC, Schutte B, Reutelingsperger CP. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine expo- sure. Cytometry 1998; 31: 1–9.
   Google Scholar
• Zhang G, Gurtu V, Kain SR, Yan G. Early detection of apoptosis using a fluorescent conjugate of annexin V. Biotechniques 1997; 23: 525–531.
   PubMed Web of Science ®Google Scholar
• Mollenhauer J, Mok MT, King KB et al. Expression of anchorin CII (cartilage annexin V) in human young, normal adult, and osteoarthritic cartilage. J Histochem Cytochem 1999; 47: 209–220.
   Google Scholar
• Kawaminami M, Kawamoto T, Tanabe T et al. Immunocyto- chemical localization of annexin V, a calcium-dependent phospholipid-binding protein, in rat endocrine organs. Cell Tissue Res 1998; 292: 85–89.
   Google Scholar
• Gotow T, Sakata M, Funakoshi T, Uchiyama Y. Preferential localization of annexin V to the axon terminal. Neuroscience 1996; 75: 507–521.
   PubMed Web of Science ®Google Scholar
• Spreca A, Rambotti MG, Giambanco I et al. Immunocytochem- ical localization of annexin V (CaBP33), a Ca2z-dependent phospholipid- and membrane-binding protein, in the rat nervous system and skeletal muscles in the porcine heart. J Cell Physiol 1992; 152: 587–598.
   Google Scholar
• Sun J, Salem HH, Bird P. Nucleolar and cytoplasmic localization of annexin V. FEBS Lett 1992; 314: 425–429.
   PubMed Web of Science ®Google Scholar
• Barwise JL, Walker JH. Subcellular localization of annexin V in human foreskin fibroblasts: nuclear localization depends on growth state. FEBS Lett 1996; 394: 213–216.
   PubMed Web of Science ®Google Scholar
• Jans SW, de Jong YF, Reutelingsperger CP, van der Vusse GJ, van Bilsen M. Differential expression and localization of annexin V in cardiac myocytes during growth and hypertrophy. Mol Cell Biochem 1998; 178: 229–236.
   PubMed Web of Science ®Google Scholar
• Arcuri C, Giambanco I, Bianchi R, Donato R. Annexin V, annexin VI, S100A1 and S100B in developing and adult avian skeletal muscles. Neuroscience 2002; 109: 371–388.
   PubMed Web of Science ®Google Scholar
• van den Eijnde SM, van den Hoff MJ, Reutelingsperger CP et al. Transient expression of phosphatidylserine at cell-cell contact areas is required for myotube formation. J Cell Sci 2001; 114: 3631–3642.
   Google Scholar
• Dubois T, Oudinet JP, Russo-Marie F, Rothhut B. In vivo and in vitro phosphorylation of annexin II in T-cells: potential regulation by annexin V. Biochem J 1995; 310: 243–248.
   PubMed Web of Science ®Google Scholar
• Romisch J, Schorlemmer U, Fickenscher K, Paques EP, Heimburger N. Anticoagulant properties of placenta protein 4 (annexin V). Thromb Res 1990; 60: 355–366.
   PubMed Web of Science ®Google Scholar
• Takei N, Ohsawa K, Imai Y, Nakao H, Iwasaki A, Kohsaka S. Neurotrophic effects of annexin V on cultured neurons from embryonic rat brain. Neurosci Lett 1994; 171: 59–62.
   PubMed Web of Science ®Google Scholar
• Clark DM, Moss SE, Wright NA, Crumpton MJ. Expression of annexin VI (p68, 67 kDa-calelectrin) in normal human tissues: evidence for developmental regulation in B- and T-lymphocytes. Histochemistry 1991; 96: 405–412.
   PubMedGoogle Scholar
• Diaz-Munoz M, Hamilton S, Kaetzel MA, Hazarika P, Dedman JR. Modulation of Ca2z release channel activity from sarco- plasmic reticulum by annexin VI (67-kDa calcimedin). J BiolChem 1990; 265: 15894–15899.
   PubMed Web of Science ®Google Scholar
• Sorrentino V, Volpe P. Ryanodine receptors: how many, where, and why? Trends Pharmacol Sci 1993; 14: 98–103.
   PubMed Web of Science ®Google Scholar
• Srivastava M, Pollard HB. Low in vivo levels of human annexin VII gene expression are due to endogenous inhibitory promoter sequences. Cell Biol Int 2000; 24: 474–481.
   Web of Science ®Google Scholar
• Ernst JD, Meers P, Hong K, Duzgunes N, Papahadjopoulos D, Goldstein IM. Human polymorphonuclear leukocytes contain synexin, a calcium-binding protein that mediates membrane fusion. Trans Assoc Am Phys 1986; 99: 58–66.
   PubMedGoogle Scholar
• Pollard HB, Burns AL, Rojas E. A molecular basis for synexin- driven, calcium-dependent membrane fusion. J Exp Biol 1988; 139: 267–286.
   PubMed Web of Science ®Google Scholar
• Pollard HB, Burns AL, Rojas E. Synexin, a new member of the annexin gene family, is a calcium channel and a membrane fusion protein. Prog Clin Biol Res 1990; 349: 159–172.
   PubMedGoogle Scholar
• Pollard HB, Rojas E, Burns AL. Synexin (annexin VII) and membrane fusion during the process of exocytotic secretion. Prog Brain Res 1992; 92: 247–255.
   PubMed Web of Science ®Google Scholar